COTEMPLA Trademark

Trademark Overview

On Friday, September 2, 2016, a trademark application was filed for COTEMPLA with the United States Patent and Trademark Office. The USPTO has given the COTEMPLA trademark a serial number of 87160228. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, March 24, 2020. This trademark is owned by Neos Therapeutics, Inc.. The COTEMPLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of disease and disorders of the central nervous system
cotempla

General Information

Serial Number87160228
Word MarkCOTEMPLA
Filing DateFriday, September 2, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, March 24, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of disease and disorders of the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 8, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeos Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Prairie, TX 75050
Party NameNeos Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Prairie, TX 75050

Trademark Events

Event DateEvent Description
Friday, May 29, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, May 28, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2019EXTENSION 5 GRANTED
Tuesday, September 17, 2019EXTENSION 5 FILED
Friday, September 20, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 17, 2019TEAS EXTENSION RECEIVED
Tuesday, March 19, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 19, 2019EXTENSION 4 GRANTED
Tuesday, March 19, 2019EXTENSION 4 FILED
Tuesday, March 19, 2019TEAS EXTENSION RECEIVED
Thursday, September 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 18, 2018EXTENSION 3 GRANTED
Tuesday, September 18, 2018EXTENSION 3 FILED
Tuesday, September 18, 2018TEAS EXTENSION RECEIVED
Monday, August 13, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 13, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 19, 2018EXTENSION 2 GRANTED
Monday, March 19, 2018EXTENSION 2 FILED
Monday, March 19, 2018TEAS EXTENSION RECEIVED
Friday, July 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 12, 2017EXTENSION 1 GRANTED
Wednesday, July 12, 2017EXTENSION 1 FILED
Wednesday, July 12, 2017TEAS EXTENSION RECEIVED
Tuesday, March 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 12, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 12, 2016ASSIGNED TO EXAMINER
Thursday, September 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 6, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

cotempla central nervous system disorders disease preparations treatment pharmaceutical